QRG Capital Management Inc. Has $1.03 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

QRG Capital Management Inc. increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 84.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,139 shares of the company's stock after purchasing an additional 6,011 shares during the period. QRG Capital Management Inc.'s holdings in GE HealthCare Technologies were worth $1,027,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Mesirow Financial Investment Management Inc. raised its stake in GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company's stock worth $383,000 after buying an additional 1,159 shares during the period. Cathy Pareto & Associates Inc. bought a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $670,000. LMR Partners LLP acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $7,387,000. Principal Financial Group Inc. grew its position in shares of GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock valued at $94,780,000 after purchasing an additional 19,010 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in GE HealthCare Technologies during the 3rd quarter worth approximately $1,396,000. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded up $1.17 during midday trading on Friday, reaching $86.58. 4,074,851 shares of the company's stock were exchanged, compared to its average volume of 2,984,002. The stock's 50-day simple moving average is $86.63 and its 200 day simple moving average is $86.13. The firm has a market cap of $39.59 billion, a price-to-earnings ratio of 20.00, a P/E/G ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on GEHC. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and an average target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.